|
RSBN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.443260E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.089170E-01 |
| Normal-vs-Stage2 |
2.424600E-01 |
| Normal-vs-Stage3 |
1.421810E-04 |
| Normal-vs-Stage4 |
4.35100000029109E-07 |
| Stage1-vs-Stage2 |
6.790800E-01 |
| Stage1-vs-Stage3 |
6.595000E-03 |
| Stage1-vs-Stage4 |
3.66320000000364E-05 |
| Stage2-vs-Stage3 |
3.490800E-01 |
| Stage2-vs-Stage4 |
1.240790E-01 |
| Stage3-vs-Stage4 |
2.523200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.938500E-03 |
| Normal-vs-AfricanAmerican |
3.225300E-04 |
| Normal-vs-Asian |
6.056400E-01 |
| Caucasian-vs-AfricanAmerican |
1.140970E-01 |
| Caucasian-vs-Asian |
2.347400E-01 |
| AfricanAmerican-vs-Asian |
5.321900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.766600E-04 |
| Normal-vs-Female |
2.189800E-02 |
| Male-vs-Female |
3.615400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.404200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.829700E-02 |
| Normal-vs-Age(61-80Yrs) |
8.389300E-04 |
| Normal-vs-Age(81-100Yrs) |
9.571900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.781200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.629400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.223600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.368000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.439800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.886580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.155800E-01 |
| Normal-vs-Grade 2 |
6.548600E-01 |
| Normal-vs-Grade 3 |
1.65970000000071E-05 |
| Normal-vs-Grade 4 |
1.9992996147522E-10 |
| Grade 1-vs-Grade 2 |
3.255800E-01 |
| Grade 1-vs-Grade 3 |
7.752500E-04 |
| Grade 1-vs-Grade 4 |
1.31859999996653E-06 |
| Grade 2-vs-Grade 3 |
2.3112999999908E-05 |
| Grade 2-vs-Grade 4 |
3.42709971512534E-10 |
| Grade 3-vs-Grade 4 |
2.424000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.070800E-01 |
| Normal-vs-ccB subtype |
1.22150000003707E-06 |
| ccA subtype-vs-ccB subtype |
7.40070005278426E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.918700E-03 |
| Normal-vs-N1 |
1.276080E-03 |
| N0-vs-N1 |
1.792610E-01 |
|
|
